Johnson & Johnson
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Johnson & Johnson
Jun 21, 2024, 13:43 |
Insight
Luca Dezzani: We are requesting approval from the U.S. FDA EGFR-mutated NSCLC therapy
Luca Dezzani, Vice President of US Oncology Medical Affairs at Johnson & Johnson, shared a…
Mar 11, 2024, 00:11 |
Career
Mary Kate Weber: I've stepped into the role of Associate Director, Patient and Caregiver Solutions - Oncology within the PECS organization at Johnson & Johnson!
Mary Kate Weber, Associate Director, Patient & Caregiver Solutions - Oncology at Johnson & Johnson,…
Nov 9, 2023, 18:59 |
Drugs
Najat Khan: Lots of buzz about the future of drug discovery
Najat Khan, Chief Data Science Officer & SVP/Global Head at Johnson & Johnson, made the…
Oct 7, 2023, 19:42 |
Blog
Najat Khan: The results of the world’s largest blood biomarker study have been published in Nature, opening up new possibilities for scientific research.
Najat Khan, Chief Data Science Officer & SVP/Global Head, Strategy, Portfolio, Ops, R&D, J&J at…
Sep 15, 2023, 18:40 |
Blog
Warm welcome and congratulations to CancerX’s inaugural steering committee, which provides an additional layer of governance within our public-private partnership model. - CancerX Moonshot
All:
5
Posts:
1 - 100
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Monica Bertagnolli: Molecular Portrait of Key Driver of pancreatic cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube